Download PDF
CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2015; 02(01): 055-057
DOI: 10.4103/2348-0548.148393
Case Report
Thieme Medical and Scientific Publishers Private Ltd.

Profound hypertension with dexmedetomidine during insertion of deep brain stimulator

Allison Tedder
1   Department of Anesthesia, University of Toronto, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada
,
Evgeny Rakhman
1   Department of Anesthesia, University of Toronto, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada
,
Pirjo Manninen
1   Department of Anesthesia, University of Toronto, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada
,
Lashmikumar Venkatraghavan
1   Department of Anesthesia, University of Toronto, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Publication Date:
05 May 2018 (online)

Also available at
   Permissions and Reprints

Abstract

Dexmedetomidine is now frequently used in the anaesthetic management of patients undergoing deep brain stimulator insertion for movement disorders. We present two patients with Parkinson’s disease and dystonia who developed marked increase in blood pressure and level of sedation during the infusion of a loading dose of dexmedetomidine (1 mcg/kg over 10 min). Both patients required treatment of their blood pressure. The first patient also had a computed tomography of the brain to rule out an intracranial event. The patients recovered from these untoward events in approximately 30 min. The possible explanations for both the hypertension and oversedation were underestimation of the severity of the patients’ underlying disease process and a relative overdose of the loading dose of dexmedetomidine.

Keywords

Deep brain stimulation - dexmedetomidine - hypertension - Parkinson’s disease
 

  • REFERENCES

  • 1 Rozet I. Anesthesia for functional neurosurgery: The role of dexmedetomidine. Curr Opin Anaesthesiol 2008; 21: 537-43
    CrossrefPubMedSearch in Google Scholar
  • 2 Bekker A, Sturaitis MK. Dexmedetomidine for neurological surgery. Neurosurgery 2005; 57: 1-10
    PubMedSearch in Google Scholar
  • 3 Rozet I, Muangman S, Vavilala MS, Lee LA, Souter MJ, Domino KJ. et al. Clinical experience with dexmedetomidine for implantation of deep brain stimulators in Parkinson's disease. Anesth Analg 2006; 103: 1224-8
    CrossrefPubMedSearch in Google Scholar
  • 4 Maurtua MA, Cata JP, Martirena M, Deogaonkar M, Rezai A, Sung W. et al. Dexmedetomidine for deep brain stimulator placement in a child with primary generalized dystonia: Case report and literature review. J Clin Anesth 2009; 21: 213-6
    CrossrefPubMedSearch in Google Scholar
  • 5 Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB. et al. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: Study with intravenous midazolam. J Clin Psychopharmacol 1990; 10: 244-51
    PubMedSearch in Google Scholar
  • 6 Bajwa S, Kulshrestha A. Dexmedetomidine: An adjuvant making large inroads into clinical practice. Ann Med Health Sci Res 2013; 3: 475-83
    CrossrefPubMedSearch in Google Scholar
  • 7 Bloor BC, Ward DS, Belleville JP, Maze M. Effects ofintravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992; 77: 1134-42
    CrossrefPubMedSearch in Google Scholar
  • 8 Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993; 78: 813-20
    CrossrefPubMedSearch in Google Scholar